# The Relationship Between the Residual Renal Function and Osteoporosis Treatment

> **NCT02304887** · — · UNKNOWN · sponsor: **Toshihiko Kono** · enrollment: 1000 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Bis, SERM Teriparatide, Denosumab

## Key facts

- **NCT ID:** NCT02304887
- **Lead sponsor:** Toshihiko Kono
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02304887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02304887, "The Relationship Between the Residual Renal Function and Osteoporosis Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02304887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*